Lefamulin-话题@MedSci - 梅斯（MedSci）

#Lefamulin#

4篇内容 | 1058人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1569877, encodeId=db7515698e789, content=<a href='/topic/show?id=5f2610e967c' target=_blank style='color:#2F92EE;'>#Lefamulin#</a>, objectTitle=XENLETA（lefamulin）治疗社区获得性肺炎（CAP）：欧盟CHMP持积极意见, objectType=article, longId=195115, objectId=8abe195115e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8abe195115e7, replyNumber=0, likeNumber=66, createdTime=2020-06-03, rootId=0, userName=chenlianhui, userId=431f15588829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8abe195115e7, moduleTitle=XENLETA（lefamulin）治疗社区获得性肺炎（CAP）：欧盟CHMP持积极意见, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8abe195115e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1569876, encodeId=21b915698e695, content=<a href='/topic/show?id=5f2610e967c' target=_blank style='color:#2F92EE;'>#Lefamulin#</a>, objectTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, objectType=article, longId=160894, objectId=0a9b1608940f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9b1608940f, replyNumber=0, likeNumber=63, createdTime=2019-02-25, rootId=0, userName=chenlianhui, userId=431f15588829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9b1608940f, moduleTitle=FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a9b1608940f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1569875, encodeId=96aa15698e5b7, content=<a href='/topic/show?id=5f2610e967c' target=_blank style='color:#2F92EE;'>#Lefamulin#</a>, objectTitle=Nabriva新型抗生素Lefamulin的胃肠道副作用, objectType=article, longId=138883, objectId=031013888329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=031013888329, replyNumber=0, likeNumber=62, createdTime=2018-05-24, rootId=0, userName=chenlianhui, userId=431f15588829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=031013888329, moduleTitle=Nabriva新型抗生素Lefamulin的胃肠道副作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=031013888329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1569874, encodeId=1cef15698e4d6, content=<a href='/topic/show?id=5f2610e967c' target=_blank style='color:#2F92EE;'>#Lefamulin#</a>, objectTitle=【研发日报】Nabriva公司新型抗生素lefamulin显示肺炎疗效, objectType=article, longId=113368, objectId=b162113368e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b162113368e8, replyNumber=0, likeNumber=75, createdTime=2017-09-21, rootId=0, userName=chenlianhui, userId=431f15588829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b162113368e8, moduleTitle=【研发日报】Nabriva公司新型抗生素lefamulin显示肺炎疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b162113368e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Lefamulin

2020-05-29

chenlianhui (审核中...)

前往app查看评论内容

#Lefamulin#

XENLETA（lefamulin）治疗社区获得性肺炎（CAP）：欧盟CHMP持积极意见

2020-06-03

chenlianhui (审核中...)

前往app查看评论内容

#Lefamulin#

FDA接受Lefamulin治疗成人社区获得性细菌性肺炎的新药申请

2019-02-25

chenlianhui (审核中...)

前往app查看评论内容

#Lefamulin#

Nabriva新型抗生素Lefamulin的胃肠道副作用

2018-05-24

chenlianhui (审核中...)

前往app查看评论内容

#Lefamulin#

【研发日报】Nabriva公司新型抗生素lefamulin显示肺炎疗效

2017-09-21

科室
- - 订阅+
  - 更多科室
工具
服务